Tramadol reduces myocardial infarct size and expression and activation of nuclear factor kappa B in acute myocardial infarction in rats

European Journal of Anaesthesiology

Volumn 26, Issue 12, 2009, Pages 1048-1055

  Zhang, Lin Zhong ^a   Guo, Zheng ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Infarct size; Myocardial infarction; Nuclear factor kappa B; Tramadol

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; TRAMADOL; TRANSCRIPTION FACTOR RELA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NARCOTIC ANALGESIC AGENT;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; FLOW CYTOMETRY; HEART INFARCTION SIZE; HEART PROTECTION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; ANIMAL; DISEASE MODEL; HEART INFARCTION; METABOLISM; PATHOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ANALGESICS, OPIOID; ANIMALS; DISEASE MODELS, ANIMAL; INTERCELLULAR ADHESION MOLECULE-1; MALE; MYOCARDIAL INFARCTION; NF-KAPPA B; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TRAMADOL; TREATMENT OUTCOME;

EID: 77449105431     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e32832c785d     Document Type: Article

References (44)

1. Minguet G, Joris J, Lamy M. Preconditioning and protection against ischaemia-reperfusion in noncardiac organs: a place for volatile anaesthetics? Eur J Anaesthesiol 2007; 24733-745.
2. Kobayashi I, Kokita N, Namiki A. Propofol attenuates ischaemia- reperfusion injury in the rat heart in vivo. Eur J Anaesthesiol 2008; 25144-151.
3. Pagel PS, Krolikowski JG. Transient metabolic alkalosis during early reperfusion abolishes helium preconditioning against myocardial infarction: restoration of cardioprotection by cyclosporin A in rabbits. Anesth Analg 2009; 1081076-1082.
4. Xu J-J, Wang Y-L. Propofol attenuation of hydrogen peroxide-mediated oxidative stress and apoptosis in cultured cardiomyocytes involves haem oxygenase-1. Eur J Anaesthesiol 2008; 25395-402.
5. Hieber S, Huhn R, Hollmann MW, et al. Hypoxia-inducible factor 1 and related gene products in anaesthetic-induced preconditioning. Eur J Anaesthesiol 2009; 26201-206.
6. Bilir A, Erkasap N, Koken T, et al. Effects of tramadol on myocardial ischemia-reperfusion injury. Scand Cardiovasc J 2007; 41242-247.
7. Kukreja RC. NFkappaB activation during ischemia/reperfusion in heart: friend or foe? J Mol Cell Cardiol 2002; 341301-1304.
8. Kin H, Wang NP, Halkos ME, et al. Neutrophil depletion reduces myocardial apoptosis and attenuates NF-kB activation/TNF-a release after ischemia and reperfusion. J Surg Res 2006; 135170-178.
9. Brown M, McGuinness M, Wright T, et al. Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo. Am J Physiol Heart Circ Physiol 2005; 289H466-H476.
10. Moss NC, Stansfield WE, Tang R, Selzman CH. Delayed NF-kappaB inhibition still provides cardioprotection from myocardial ischemia and reperfusion. J Am Coll Surg 2007; 205S95-S96.
11. Valen G, Yan ZQ, Hansson GK. Nuclearfactor kappa-B and the heart. J Am Coll Cardiol 2001; 38307-314.
12. Hall G, Hasday JD, Rogers TB. Regulating the regulator: NF-kappaB signaling in heart. J Mol Cell Cardiol 2006; 41 580-591.
13. Chandrasekar B, Freeman GL. Induction of nuclear factor kappaB and activation protein 1 in postischemic myocardium. FEBS Lett 1997; 401 30-34.
14. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 5331-47.
15. Sun Y, Zhang J, Lu L, et al. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am J Pathol 2002; 161 1773-1781.
16. Ogata T, Miyauchi T, Sakai S, et al. Myocardial fibrosis and diastolic dysfunction in deoxycorticosterone acetate-salt hypertensive rats is ameliorated by the peroxisome proliferator-activated receptor-alpha activator fenofibrate, partly by suppressing inflammatory responses associated with the nuclear factorkappa-B pathway. J Am Coll Cardiol 2004; 431481-1488.
17. Huang H, Petkova SB, Cohen AW, et al. Activation of transcription factors AP-1 and NF-kappa B in murine Chagasic myocarditis. InfectImmun 2003; 712859-2867.
18. Baeuerle PA, Henkel T. Function and activation of NF-kB in the immune system. Annu Rev Immunol 1994; 12141-179.
19. Collins T, Read MA, Neish AS, et al. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J 1995; 9899-909.
20. Iademarco MF, McQuillan JJ, Rosen GD, Dean DC. Characterization of the promoter for vascular cell adhesion molecule-1. J Biol Chem 1992; 26716323-16329.
21. -1 gene by inflammatory cytokines in human endothelial cells. J Biol Chem 1995; 270933-943.
22. Ma X, Lefer DJ, Lefer AM, Rothline R. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion. Circulation 1992; 86937-946.
23. Weyrich AS, Ma X, Lefer DJ, et al. In vivo neutralization of P-selectin protects feline heart and endothelium in myocardial ischemia and reperfusion injury. J Clin Invest 1993; 91 2620-2629.
24. Yamazaki T, Seko Y, Tamatani T, et al. Expression of intercellular adhesion molecule-1 in rat heart with ischemia/reperfusion and limitation of infarct size by treatment with antibodies against cell adhesion molecules. Am J Pathol 1993; 143410-418.
25. Hartman JC, Anderson DC, Wiltse AL, et al. Protection of ischemic/ reperfused canine myocardium by CL18/6, a monoclonal antibody to adhesion molecule ICAM-1. Cardiovasc Res 1995; 3047-54.
26. Lefer DJ, Flynn DM, Anderson DC, Buda AJ. Combined inhibition of P-selectin and ICAM-1 reduces myocardial injury following ischemia and reperfusion. Am J Physiol 1996; 271 H2421-H2429.
27. Zhang JW, Guo Z. Changes in substance P in myocardial and dorsal root ganglion following coronary artery occlusion in rats. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2006; 18201-205.
28. Guo Z, Niu YL, Zhang JW, Yao TP. Coronary artery occlusion alters expression of substance P and its mRNA in spinal dorsal horn in rats. Neuroscience 2007; 145669-675.
29. Cohen C, Tickman RJ, Derose PB, Whitaker BP. DNA ploidy studies of benign and malignant tumors. Comparison of flow cytometry and image analysis techniques using two types of cytological specimen. Cytopathology 1991; 2241-259.
30. Foulds S. Flow cytometric method for quantifying nuclear binding of the transcription factor nuclear factor kappa B in unseparated human monocytes and polymorphonuclear cells. Cytometry1997; 29182-186.
31. Deptala A, Bedner E, Gorczyca W, Darzynkiewicz Z. Activation of nuclear factor kappa B (NF-kappaB) assayed by laser scanning cytometry (LSC). Cytometry1998; 33376-382.
32. Okuducu H, Onal SA. Is nitric oxide involved in the antinociceptive activity of tramadol? Findings in a ratmodel of neuropathic pain. AgriDergisi2005; 1731-40.
33. Dal D, Salman MA, Salman AE, et al. The involvement of nitric oxide on the analgesic effect of tramadol. Eur J Anaesthesiol 2006; 23175-177.
34. Kaya T, Gursoy S, Karadas B, et al. High-concentration tramadol-induced vasodilation in rabbitaorta is mediated byboth endothelium-dependentand- independent mechanisms. Acta Pharmacol Sin 2003; 24385-389.
35. Spiecker M, Peng HB, Liao JK. Inhibition of endothelial vascular cell adhesion molecule-1 expression by nitric oxide involves the induction and nuclear translocation of IkBa. J Biol Chem 1997; 27230969-30974.
36. Peng HB, Libby P, Liao JK. Induction and stabilization of IkBa by nitric oxide mediates inhibition of NF-kB. J Biol Chem 1995; 27014214-14219.
37. Matthews JR, Botting CH, Panico M, et al. Inhibition of NF-kB DNA binding by nitric oxide. Nucleic Acids Res 1996; 242236-2242.
38. Mehta JL, Li DY. Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain? Cardiovasc Res 1999; 43291-299.
39. Chen F, Castranova V, Shi X, Demers LM. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999; 457-17.
40. Li C, Kao RL, Ha T, et al. Early activation of IKKb during in vivo myocardial ischemia. Am J Physiol Heart Circ Physiol 2001; 280H1264-H1271.
41. Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element 'decoy' against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3894-899.
42. Sakaguchi T, Sawa Y, Fukushima N, et al. A novel strategy of decoy transfection against nuclear factor-kappaB in myocardial preservation. Ann Thorac Surg 2001; 71 624-629; discussion 629-630.
43. Dawn B, Guo Y, Rezazadeh A, et al. Tumor necrosis factor-a does not modulate ischemia/reperfusion injury in naive myocardium but is essential for the development of late preconditioning. J Mol Cell Cardiol 2004; 3751-61.
44. Maulik N, Sato M, Price BD, Das DK. An essential role of NFkB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 1998; 429365-369.